Diagnoses AML/MDS (n=23) ALL (n=8) Scleroderma (7) Non-Hodgkin's Lymphoma (n=5) CML (n=1) CLL (n=1)
Prior chemotherapy n=37
Patients undergoing either non-myeloablative or myeloablative allogeneic or autologous stem cell transplantation were eligible for enrollment. All irradiation conditioning was completed 18 hours prior to the initiation of additional immunosuppressive conditioning drugs. PB samples were collected prior to and 6 hours following 200 cGy total body irradiation (nonmyeloablative conditioning) or prior to and 6 hours following the first fraction (150 cGy) of total body irradiation (myeloablative conditioning). MDS=myelodysplastic syndrome, AML=acute myelogenous leukemia, ALL=acute lymphocytic leukemia, CML=chronic myelogenous leukemia, CLL=chronic lymphocytic leukemia
